13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001387131-23-006542
Total Value
$738.6M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 5,858,262 | $173.6M | 23.50% |
| 2 | Dyne Therapeutics, Inc. | DYN | 9,885,449 | $113.9M | 15.42% |
| 3 | Day One Biopharmaceuticals, Inc. | DAWN | 7,608,394 | $101.7M | 13.77% |
| 4 | Disc Medicine, Inc. | IRON | 3,461,784 | $73.4M | 9.93% |
| 5 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $57.1M | 7.74% |
| 6 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $44.9M | 6.08% |
| 7 | Aerovate Therapeutics, Inc. | 008064107 | 2,039,249 | $41.1M | 5.57% |
| 8 | Replimune Group, Inc. | REPL | 2,098,300 | $37.1M | 5.02% |
| 9 | Generation Bio, Co. | 37148K100 | 8,279,484 | $35.6M | 4.82% |
| 10 | Akero Therapeutics, Inc. | 00973Y108 | 594,251 | $22.7M | 3.08% |
| 11 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $17.3M | 2.34% |
| 12 | Xilio Therapeutics, Inc. | XLO | 2,759,344 | $8.7M | 1.18% |
| 13 | AvroBio, Inc. | 05455M100 | 4,541,381 | $4.5M | 0.61% |
| 14 | Magenta Therapeutics, Inc. | 55910K108 | 3,791,698 | $3.0M | 0.41% |
| 15 | Viridian Therapeutics, Inc. | VRDN | 90,072 | $2.3M | 0.31% |
| 16 | Spero Therapeutics, Inc. | SPRO | 1,031,160 | $1.5M | 0.20% |